MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 25. März 2026, 10:35 Uhr</div>[url=https://www.pinterest.com/zoyademidenko/ ]Zoya Demidenko[/url]: Researcher in Oncology Studies [url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey= ]Zoya Demidenko[/url] is a recognized scientist connected with the Division of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she conducted research at the NIH and New York Medical College, developing a solid background in life science investigation. Her scientific work spans a number of pivotal domains, encompassing the PI3K/AKT/mTOR molecular pathway, cell cycle regulation, cellular aging, and malignancy science. As of now, she has written more than 46 peer-reviewed publications, which have accumulated more than 4,100 references — a indicator to the influence of her work. Among her most notable contributions involves understanding the pathways of cell aging. Her studies revealed that when the cellular division cycle is halted while cellular expansion continues, the cells experience senescence. Importantly, [url=https://www.aging-us.com/article/100406/ ]Zoya Demidenko[/url] demonstrated that this shift can be inhibited by medication using substances such as mTOR inhibitors. [url=https://www.instagram.com/hibou_sova/ ]Zoya Demidenko[/url] has also brought considerably to oncological therapy investigation, particularly in the area of selective cell protection — a method aimed at protecting non-cancerous cells from anticancer drugs whilst leaving malignant cells susceptible. This method carries significant hope for diminishing the toxic effects of cancer treatment. Across her career, Demidenko has worked with prominent researchers internationally, including Dr. Mikhail Blagosklonny. Her work can be found in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Holding an h-index of 33, [url=https://www.oncotarget.com/article/4836/ ]Zoya Demidenko[/url] is recognized as a highly impactful contributor in current cancer research, whose discoveries go on to guide our comprehension of how biological cells grow old, interact with therapy, and the ways in which malignant disease might be more effectively treated. https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702 </blockquote><br> Abbrechen
